Posted Aug. 11, 2017 at 10:50 a.m.

Premium Lock Investors in Durham-based Fennec Pharmaceuticals file to sell nearly 12M shares

Published: 2017-08-11 10:50:18
Updated: 2017-08-11 10:50:18

New drugs New drugs Image 1 of 2 · Next Image…

Large investors in Fennec Pharmaceuticals, a Durham-based developmental drug company, want to sell 11.9 million shares of the company, according to a filing Thursday with the Securities and Exchange Commission....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 The University of North Carolina at Chapel Hill. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders